Edition:
United States

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

149.31USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$149.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
331,124
52-wk High
$174.99
52-wk Low
$100.20

Summary

Name Age Since Current Position

Michael Mussallem

65 2000 Chairman of the Board, Chief Executive Officer

Scott Ullem

51 2014 Chief Financial Officer, Corporate Vice President

Jean-Luc Lemercier

60 2017 Corporate Vice President, EMEA (Europe, Middle East and Africa)

Donald Bobo

56 2007 Corporate Vice President - Heart Valve Therapy

Catherine Szyman

51 2015 Corporate Vice President- Critical Care

Huimin Wang

61 2010 Corporate Vice President- Japan, Asia and Pacific

Larry Wood

52 2007 Corporate Vice President - Transcatheter Heart Valve Therapy

Kieran Gallahue

54 2015 Independent Director

Leslie Heisz

57 2016 Independent Director

William Link

72 2009 Independent Director

Steven Loranger

66 2016 Independent Director

Martha Marsh

69 2015 Independent Director

Nicholas Valeriani

61 2014 Independent Director

Wesley von Schack

73 2012 Presiding Independent Director

David Erickson

Vice President - Investor Relations

Biographies

Name Description

Michael Mussallem

Mr. Michael A. Mussallem is Chairman of the Board, Chief Executive Officer of the Edwards Lifesciences Corp. He has an extensive knowledge of the medical technology industry in general, and of the people, operations, processes and products of the Company in particular, built over a more than 35-year career with the Company and its predecessor. In addition, in his roles with AdvaMed and other healthcare-related organizations, he has become a recognized leader in the medical technology industry, making important contributions to healthcare policy discussions in California, the United States and the key global markets that the Company serves. These experiences have established relationships, which are helpful in developing our Board’s strategic perspective, and enhanced his leadership of the Company and contributions to our Board.

Scott Ullem

Mr. Scott B. Ullem has been appointed as Chief Financial Officer, Corporate Vice President of the Edwards Lifesciences Corportion effective January 2, 2014. Prior to joining Edwards, he served from May 2010 to December 2013 as Chief Financial Officer of Bemis Company Inc., a publicly traded global supplier of packaging and pressure sensitive materials used in leading food, consumer, and healthcare products. Mr. Ullem also had leadership responsibility for one of Bemis’ three business segments and the company’s information technology function. Before joining Bemis, Mr. Ullem spent 17 years in investment banking, serving as Managing Director at Goldman Sachs and later for Bank of America. He has served on the Board and Compensation Committee of Berry Plastics Group, Inc. since 2016 and is a Henry Crown Fellow at the Aspen Institute.

Jean-Luc Lemercier

Mr. Jean-Luc Lemercier has been Corporate Vice President, EMEA (Europe, Middle East and Africa) of the Edwards Lifesciences Corp, Canada and Latin America since July 2017. Prior to assuming his current role, Lemercier served as Vice President of Transcatheter Heart Valves EMEA from 2008. Under his leadership, Edwards successfully launched the SAPIEN transcatheter heart valve technology and built its leadership position in Europe. Before joining Edwards, Mr. Lemercier served in various leadership roles with Johnson & Johnson Cordis from 1996 to 2008, including leader of the structural heart disease group in the United States; Vice President of New Business Development in Europe; Vice President of the Cordis Cardiology Division in Belgium; and General Manager of Cordis France. Mr. Lemercier has more than 30 years of medical technology experience, beginning with Baxter in France, and held several sales and marketing management positions within Baxter Europe and the United States. Mr. Lemercier has served on the Board of CARMAT since January 2017.

Donald Bobo

Mr. Donald E. Bobo, Jr., is Corporate Vice President - Heart Valve Therapy of Edwards Lifesciences Corp. He is responsible for Edwards’ corporate strategy and corporate development functions. In addition, Mr. Bobo has executive responsibility for the Company’s disease awareness and heart failure initiatives, as well as the healthcare solutions and commercial services team. Mr. Bobo has more than 30 years of experience in the medical products and healthcare industry and has served in various operating roles at Edwards, including most recently, the leadership of the Company’s transcatheter mitral and tricuspid therapies organization and the global heart valve therapy business and global valve manufacturing operations. Prior to joining Edwards in 1995, Mr. Bobo held a variety of roles with increasing levels of responsibility with American Hospital Supply and Baxter Healthcare Corporation. Mr. Bobo has served on the Board of Innerspace Neuro Solutions Inc. since 2013. He has served on the Board and Executive Committee of the California Life Sciences Association since 2015 and as its Chairman of the Board since May 2017.

Catherine Szyman

Ms. Catherine M. Szyman has been Corporate Vice President, Critical Care of Edwards Lifesciences Corporation since January 2015. Prior to 2015, she was employed for more than 20 years at Medtronic, LLC, where she served as its Senior Vice President and President of Medtronic’s global diabetes business from 2009 to 2014, overseeing research, development, operations, sales and marketing for Medtronic’s insulin infusion pumps and continuous glucose monitoring systems. Prior to that, she held a variety of leadership roles at Medtronic, including Senior Vice President of Corporate Strategy and Business Development, General Manager of Endovascular Innovations and Vice President of Finance for the Cardiovascular Business. Ms. Szyman previously served on the Boards of Tornier, Inspire Medical Systems, and the California Healthcare Institute.

Huimin Wang

Dr. Huimin Wang M.D., is Corporate Vice President, Japan, Asia Pacific of Edwards Lifesciences Corporation. since 2010. From 2004 to 2010, he served as Corporate Vice President, Japan and Intercontinental Regions and was Corporate Vice President, Japan from 2000 to 2004. Previously, he served in a number of roles with Baxter Healthcare Corporation, including Senior Manager of Strategy Development, Director of Product/Therapy for the Renal Division in Japan, President of Medical Systems and Devices in Japan, and was a representative director of Baxter Limited, a Japan corporation, through September 2002. Before joining Baxter, Dr. Wang was a senior associate with Booz, Allen & Hamilton in Chicago, Vice President of Integrated Strategies, a consulting and venture management firm he co-founded, and an associate with McKinsey & Company. Dr. Wang is a Visiting Associate Professor of anesthesiology at Keio University.

Larry Wood

Mr. Larry L. Wood is Corporate Vice President - Transcatheter Heart Valve Therapy of Edwards Lifesciences Corp. since 2007, and He is responsible for Edwards’ key initiatives in transcatheter heart valve replacement around the globe, including research and development, operations, marketing, commercial clinical and regulatory initiatives. Most recently prior to his current role, from March 2004 to February 2007, he served as Vice President and General Manager, Percutaneous Valve Interventions. Mr. Wood has more than 30 years of experience in the medical technology industry at both Edwards and Baxter Healthcare Corporation in positions including manufacturing management, regulatory affairs and strategic and clinical marketing, primarily for the surgical heart valve therapy business.

Kieran Gallahue

Mr. Kieran T. Gallahue is an Independent Director of the Edwards Lifesciences Corporation. He provides valuable insights and direction to our Board gained through extensive executive management experience at medical technology companies. His leadership roles on other public company boards and committees and prior experience as a public company chief financial officer also enables him to contribute valuable financial and accounting perspectives to our Board and Audit Committee.

Leslie Heisz

Ms. Leslie Stone Heisz is an Independent Director of the Edwards Lifesciences Corp. Her career in the banking industry, in-depth knowledge of capital markets, and previous public company board and audit committee experience enhances our Board’s ability to effectively oversee financial reporting, enterprise and operational risk management, as well as corporate finance, tax, treasury, and governance matters.

William Link

Dr. William J. Link, Ph.D., is an Independent Director of the Edwards Lifesciences Corp. His corporate leadership and long history successfully commercializing products in the medical technology industry provide the Board with a valuable perspective in evaluating the prospects of, and risks associated with, existing business operations. In addition, his extensive experience in identifying new business opportunities and his strong technical and engineering background have proven beneficial in assessing the potential for future innovations. He earned his bachelor's, master's and doctoral degrees in mechanical engineering from Purdue University.

Steven Loranger

Mr. Steven R. Loranger is an Independent Director of the Edwards Lifesciences Corp. He is a seasoned executive with global manufacturing and operational experience in highly regulated, high-tech industries. His decades of experience leading large, global innovation-focused corporations with intensive data privacy components is particularly valuable to the Board. He holds a bachelor's and master's degree in science from the University of Colorado.

Martha Marsh

Ms. Martha H. Marsh is Independent Director of the Edwards Lifesciences Corp. Her experience of more than 30 years in an increasingly complex and evolving healthcare system as a president and chief executive officer, combined with years of Board experience that includes corporate governance chairmanships, provide a unique perspective as our board considers the execution of our patient-focused innovation strategy. She received her Bachelor of Arts in History from the University of Rochester, an MBA in accounting and health administration and a master's degree in public health from Columbia University.

Nicholas Valeriani

Mr. Nicholas J. Valeriani is an Independent Director of the Edwards Lifesciences Corp. since November, 2014. His 40 years of medical technology industry experience in a large and complex global company and experience directing strategy informs his contribution to the development of our innovation strategy and assessment of future business opportunities. In addition, his background in human resources enables him to contribute valuable insights to the Compensation and Governance Committee. He received a bachelor's degree in industrial engineering and an MBA from Rutgers University.

Wesley von Schack

Dr. Wesley W. von Schack is the Presiding Independent Director of the Edwards Lifesciences Corp. His experience of more than 30 years in the highly regulated energy industry as both a chief executive officer and a chief financial officer, combined with many years of Board experience and audit and compensation committee chairmanships, enable him to make significant contributions in assessing and managing risks. In addition, the operational and leadership skills developed over his career have provided valuable insights and support to the Board as its Presiding Director. He received his Bachelor of Economics from Fordham University, an MBA from St. John's University and a Ph.D. from Pace University.

David Erickson

Basic Compensation

Name Fiscal Year Total

Michael Mussallem

10,798,300

Scott Ullem

3,184,570

Jean-Luc Lemercier

--

Donald Bobo

3,149,090

Catherine Szyman

2,917,380

Huimin Wang

--

Larry Wood

3,121,780

Kieran Gallahue

299,300

Leslie Heisz

318,300

William Link

312,967

Steven Loranger

293,967

Martha Marsh

293,940

Nicholas Valeriani

293,940

Wesley von Schack

328,967

David Erickson

--
As Of  30 Dec 2017